Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1959 2
1961 2
1962 6
1965 1
1966 1
1967 1
1968 2
1969 3
1970 3
1972 1
1973 2
1974 1
1975 2
1977 2
1978 1
1979 1
1980 2
1981 4
1982 2
1983 12
1984 8
1985 5
1986 2
1987 5
1988 1
1989 8
1990 4
1991 2
1992 5
1993 7
1994 9
1995 1
1996 3
1997 2
1998 3
1999 4
2000 2
2001 2
2002 5
2003 5
2004 5
2005 7
2006 8
2007 13
2008 12
2009 2
2010 7
2011 11
2012 7
2013 8
2014 9
2015 16
2016 22
2017 25
2018 20
2019 33
2020 35
2021 39
2022 32
2023 28
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

438 results

Results by year

Filters applied: . Clear all
Page 1
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma.
Leonard JP, Trneny M, Izutsu K, Fowler NH, Hong X, Zhu J, Zhang H, Offner F, Scheliga A, Nowakowski GS, Pinto A, Re F, Fogliatto LM, Scheinberg P, Flinn IW, Moreira C, Cabeçadas J, Liu D, Kalambakas S, Fustier P, Wu C, Gribben JG; AUGMENT Trial Investigators. Leonard JP, et al. Among authors: re f. J Clin Oncol. 2019 May 10;37(14):1188-1199. doi: 10.1200/JCO.19.00010. Epub 2019 Mar 21. J Clin Oncol. 2019. PMID: 30897038 Free PMC article. Clinical Trial.
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi.
Merli F, Luminari S, Tucci A, Arcari A, Rigacci L, Hawkes E, Chiattone CS, Cavallo F, Cabras G, Alvarez I, Fabbri A, Re A, Puccini B, Barraclough A, Delamain MT, Ferrero S, Usai SV, Ferrari A, Cencini E, Pennese E, Zilioli VR, Marino D, Balzarotti M, Cox MC, Zanni M, Di Rocco A, Lleshi A, Botto B, Hohaus S, Merli M, Sartori R, Gini G, Nassi L, Musuraca G, Tani M, Bottelli C, Kovalchuk S, Re F, Flenghi L, Molinari A, Tarantini G, Chimienti E, Marcheselli L, Mammi C, Spina M. Merli F, et al. Among authors: re f. J Clin Oncol. 2021 Apr 10;39(11):1214-1222. doi: 10.1200/JCO.20.02465. Epub 2021 Feb 12. J Clin Oncol. 2021. PMID: 33577377 Free article.
MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial.
Ferreri AJM, Doorduijn JK, Re A, Cabras MG, Smith J, Ilariucci F, Luppi M, Calimeri T, Cattaneo C, Khwaja J, Botto B, Cellini C, Nassi L, Linton K, McKay P, Olivieri J, Patti C, Re F, Fanni A, Singh V, Bromberg JEC, Cozens K, Gastaldi E, Bernardi M, Cascavilla N, Davies A, Fox CP, Frezzato M, Osborne W, Liberati AM, Novak U, Zambello R, Zucca E, Cwynarski K; International Extranodal Lymphoma Study Group (IELSG). Ferreri AJM, et al. Among authors: re f. Lancet Haematol. 2021 Feb;8(2):e110-e121. doi: 10.1016/S2352-3026(20)30366-5. Lancet Haematol. 2021. PMID: 33513372 Free PMC article. Clinical Trial.
Nanomedicine for the Treatment of Alzheimer's Disease.
Formicola B, Cox A, Dal Magro R, Masserini M, Re F. Formicola B, et al. Among authors: re f. J Biomed Nanotechnol. 2019 Oct 1;15(10):1997-2024. doi: 10.1166/jbn.2019.2837. J Biomed Nanotechnol. 2019. PMID: 31462368 Review.
Phage-displayed peptides targeting specific tissues and organs.
Andrieu J, Re F, Russo L, Nicotra F. Andrieu J, et al. Among authors: re f. J Drug Target. 2019 Jun-Jul;27(5-6):555-565. doi: 10.1080/1061186X.2018.1531419. Epub 2018 Oct 24. J Drug Target. 2019. PMID: 30281393 Free article. Review.
Glutathione and detoxification.
Tedeschi M, Bohm S, Di Re F, Oriana S, Spatti GB, Tognella S, Zunino F. Tedeschi M, et al. Among authors: di re f. Cancer Treat Rev. 1990 Sep;17(2-3):203-8. doi: 10.1016/0305-7372(90)90048-k. Cancer Treat Rev. 1990. PMID: 2272034 Review. No abstract available.
Editorial: Delivering nucleic acids to immune and non-immune cells.
Afonin KA, Re F, Boraschi D. Afonin KA, et al. Among authors: re f. Front Immunol. 2023 Aug 8;14:1237506. doi: 10.3389/fimmu.2023.1237506. eCollection 2023. Front Immunol. 2023. PMID: 37614239 Free PMC article. No abstract available.
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity.
Re F, Giorgetti S, Biondi B, Scapin S, Mantegazza F, Cassina V, Sesana SM, Rizzi L, Eberini I, Palazzolo L, Beeg M, Gobbi M, Sardina M, Masserini M. Re F, et al. Ann Med. 2023 Dec;55(1):2205659. doi: 10.1080/07853890.2023.2205659. Ann Med. 2023. PMID: 37143345 Free PMC article.
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease.
Turri M, Conti E, Pavanello C, Gastoldi F, Palumbo M, Bernini F, Aprea V, Re F, Barbiroli A, Emide D, Galimberti D, Tremolizzo L, Zimetti F, Calabresi L; AGAINST-AD Group. Turri M, et al. Among authors: re f. Alzheimers Res Ther. 2023 May 20;15(1):95. doi: 10.1186/s13195-023-01241-6. Alzheimers Res Ther. 2023. PMID: 37210544 Free PMC article.
Nanotechnology for neurodegenerative disorders.
Re F, Gregori M, Masserini M. Re F, et al. Nanomedicine. 2012 Sep;8 Suppl 1:S51-8. doi: 10.1016/j.nano.2012.05.007. Epub 2012 May 26. Nanomedicine. 2012. PMID: 22640910 Review.
438 results